Balchem Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Balchem stock.
View analyst ratings for Balchem or view top-rated stocks.

Wall Street analysts have given Balchem a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Balchem wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Balchem is scheduled to release its next quarterly earnings announcement on Friday, May 7th 2021.
View our earnings forecast for Balchem.

Balchem Co. (NASDAQ:BCPC) issued its earnings results on Thursday, February, 18th. The basic materials company reported $0.83 EPS for the quarter, topping the consensus estimate of $0.81 by $0.02. The basic materials company earned $180.70 million during the quarter, compared to the consensus estimate of $175.33 million. Balchem had a net margin of 12.02% and a trailing twelve-month return on equity of 14.01%. Balchem's revenue for the quarter was up 8.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.88 EPS.
View Balchem's earnings history.

Balchem's stock was trading at $89.29 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BCPC stock has increased by 37.6% and is now trading at $122.84.
View which stocks have been most impacted by COVID-19.

Balchem announced an annual dividend on Thursday, December 17th. Stockholders of record on Monday, December 28th will be paid a dividend of $0.58 per share on Friday, January 22nd. This represents a dividend yield of 0.5%. The ex-dividend date is Thursday, December 24th. This is a positive change from Balchem's previous annual dividend of $0.26.
View Balchem's dividend history.

Balchem pays an annual dividend of $0.58 per share and currently has a dividend yield of 0.48%. Balchem does not yet have a strock track record of dividend growth. The dividend payout ratio of Balchem is 18.18%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Balchem will have a dividend payout ratio of 19.27% next year. This indicates that Balchem will be able to sustain or increase its dividend.
View Balchem's dividend history.

2 brokerages have issued 1 year target prices for Balchem's stock. Their forecasts range from $140.00 to $145.00. On average, they anticipate Balchem's stock price to reach $142.50 in the next year. This suggests a possible upside of 16.0% from the stock's current price.
View analysts' price targets for Balchem or view top-rated stocks among Wall Street analysts.

15 employees have rated Balchem CEO Dino A. Rossi on Glassdoor.com. Dino A. Rossi has an approval rating of 85% among Balchem's employees.

Some companies that are related to Balchem include The Sherwin-Williams (SHW), Ecolab (ECL), International Flavors & Fragrances (IFF), Valaris (VAL), Celanese (CE), Albemarle (ALB), RPM International (RPM), Ashland Global (ASH), Quaker Chemical (KWR), W. R. Grace & Co. (GRA), NewMarket (NEU), H.B. Fuller (FUL), Sensient Technologies (SXT), Stepan (SCL) and Minerals Technologies (MTX).
View all of BCPC's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Ecolab (ECL), CVS Health (CVS), AbbVie (ABBV), Johnson & Johnson (JNJ), Lowe's Companies (LOW), Altria Group (MO), NVIDIA (NVDA), AT&T (T), Analog Devices (ADI) and Bristol-Myers Squibb (BMY).

Balchem trades on the NASDAQ under the ticker symbol "BCPC."

Balchem's stock is owned by many different institutional and retail investors. Top institutional investors include Scout Investments Inc. (0.28%), Bath Savings Trust Co (0.14%), State of Alaska Department of Revenue (0.07%), Louisiana State Employees Retirement System (0.05%), American Research & Management Co. (0.02%) and Everence Capital Management Inc. (0.02%). Company insiders that own Balchem stock include David F Ludwig and Scott C Mason.
View institutional ownership trends for Balchem.

BCPC stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Private Capital Group LLC, Bath Savings Trust Co, and Louisiana State Employees Retirement System.
View insider buying and selling activity for Balchem or view top insider-selling stocks.

BCPC stock was bought by a variety of institutional investors in the last quarter, including Scout Investments Inc., Everence Capital Management Inc., PBMares Wealth Management LLC, and American Research & Management Co..
View insider buying and selling activity for Balchem or or view top insider-buying stocks.

Shares of BCPC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BCPC stock can currently be purchased for approximately $122.84.

Balchem has a market capitalization of $3.98 billion and generates $643.71 million in revenue each year. The basic materials company earns $79.67 million in net income (profit) each year or $3.19 on an earnings per share basis.

Balchem employs 1,342 workers across the globe.

The official website for Balchem is www.balchem.com.

Balchem is headquartered at 52 Sunrise Park Road, NEW HAMPTON NY, 10958.

Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The basic materials company can be reached via phone at 845-326-5600 or via email at [email protected]